Skip to main content
Clinical Trials/IRCT20240508061704N1
IRCT20240508061704N1Not yet recruitingPhase 1

Investigating the effectiveness of extracellular vesicles released from mesenchymal stem cells in thetreatment of patients with persistent vitiligo lesions: a pilot study

Shiraz University of Medical Sciences0 sites6 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
All

Inclusion Criteria

  • Patients should have stable vitiligo
  • The patient's medical history should report the stability of the patient's disease in terms of the absence of new lesions during the last one year

Exclusion Criteria

  • Patients with more than 20% of the body surface involved with vitiligo
  • pregnant women
  • lactating women
  • patients with skin cancer
  • patients who have undergone other treatments for vitiligo in the past 3 months

Investigators

Similar Trials